Skip to Content Skip to Footer
Donald Hsu, PharmD

Donald Hsu, PharmD

Associate Dean, Academic and Student Affairs, Associate Professor, Pharmacy Practice and Administration

College of Pharmacy

Phone: 909-469-5247

  • Education

    Pharm.D. 2003
    Western University of Health Sciences

  • Education Experience


    Pharmacy Practice
    2004 University of Southern California

    Infectious Diseases
    2005 University of Southern California

  • Work Site

    St. Joseph Hospital
    1100 West Stewart Drive
    Orange, CA 92863-5600

    The medicine clerkship is designed to provide various clinical experiences necessary to prepare students to become entry level practitioners. The students will be involved in direct patient care activities in an inpatient setting and will have opportunities to work with other health care professionals. The students are expected to serve as an integral member of the multidisciplinary health care team to provide drug therapy to patients.

  • Research Interest

    Dr. Hsu's clinical and research interests are in the area of infectious diseases.

  • Publications
    1. Hong M, Bounthavong M, Hsu DI. Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase inhibitor combination. Infect Drug Resist 2013; 6:215-223.
    2. Bounthavong M, Hsu DI. Cost-effectiveness of linezolid in MRSA skin and skin-structure infections. Expert Rev Pharmacoecon Outcomes Res 2012; 12:683-698.
    3. Bach T, Hsu DI, Bounthavong M. Present and emerging therapies for methicillin-resistant Staphylococcus aureus skin and soft-tissue infection: focus on iclaprim. Clin Med Rev Ther 2011; 3.
    4. Schwartzman E, Hsu DI, Law AV, Chung EP. Assessment of patient communication skills during OSCE: Examining effectiveness of a training program in minimizing inter-grader variability. Patient Educ Couns 2011
    5. Wong SF, Lindgren T, Hsu DI, Tran G. Low dose gemcitabine plus cisplatin in previously treated, relapsed Non-Hodgkin's Lymphoma. Am J Hemat 2003; 73: 298.
    6. Hsu DI, Murthy R, Okamoto M, Wong-Beringer A. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and associated outcomes. J Antimicrob Chemother 2005; 55(4): 535-41
    7. Beringer P, Huyng K, Kriengkauykiat J, Bi L, Hoem N, Louie S, Han E, Nguyen T, Hsu DI, et al. Absolute Bioavailability and Intracellular Pharmacokinetics of Azithromycin in Patients with Cystic Fibrosis. Antimicrob. Agents Chemother. 2005 49: 5013-5017